Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.
复制标题
DOI:
10.1038/nature22341
复制
发表时间:
2017-06-22
期刊:
影响因子:
64.8
通讯作者:
Kalluri R
中科院分区:
文献类型:
--
作者:
Kamerkar S;LeBleu VS;Sugimoto H;Yang S;Ruivo CF;Melo SA;Lee JJ;Kalluri R
The mutant form of the GTPase KRAS is a key driver of pancreatic cancer but remains a challenging therapeutic target. Exosomes, extracellular vesicles generated by all cells, are naturally present in the blood. Here we demonstrate that enhanced retention of exosomes in circulation, compared to liposomes, is due to CD47 mediated protection of exosomes from phagocytosis by monocytes and macrophages. Exosomes derived from normal fibroblast-like mesenchymal cells were engineered to carry siRNA or shRNA specific to oncogenic KRASG12D (iExosomes), a common mutation in pancreatic cancer. Compared to liposomes, iExosomes target oncogenic Kras with an enhanced efficacy that is dependent on CD47, and is facilitated by macropinocytosis. iExosomes treatment suppressed cancer in multiple mouse models of pancreatic cancer and significantly increased their overall survival. Our results inform on a novel approach for direct and specific targeting of oncogenic Kras in tumors using iExosomes.
登录
查看更多内容
影响因子:
46.9
作者:
Alvarez-Erviti, Lydia;Seow, Yiqi;Wood, Matthew J. A.
通讯作者:
Wood, Matthew J. A.
影响因子:
14.9
作者:
Du, Q;Thonberg, H;Wang, J;Wahlestedt, C;Liang, ZC
通讯作者:
Liang, ZC
影响因子:
8.8
作者:
Eser, S.;Schnieke, A.;Schneider, G.;Saur, D.
通讯作者:
Saur, D.
影响因子:
4.6
作者:
Kibria G;Ramos EK;Lee KE;Bedoyan S;Huang S;Samaeekia R;Athman JJ;Harding CV;Lötvall J;Harris L;Thompson CL;Liu H
通讯作者:
Liu H
影响因子:
15.9
作者:
Collins, Meredith A.;Bednar, Filip;di Magliano, Marina Pasca
通讯作者:
di Magliano, Marina Pasca